Abbott Laboratories Aktie

106,26 EUR -0,16 EUR -0,15 %

10:31:36

STU

126,51 USD +0,83 USD +0,66 %

20:44:22

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.185,97 Mrd. EUR

KGV14,81Div. Rendite1,98%

WKN850103

ISINUS0028241000

SymbolABT

Abbott Laboratories Aktien News

Sortieren:Datum Meistgelesen

12.12.22MyDividendsAbbott Laboratories steigert die Dividende das 51. Jahr in Folge

09.12.22PR NewswireAbbott Increases Quarterly Dividend, Marking 51 Consecutive Years of Dividend Growth

17.11.22PR NewswireAbbott Receives Three CES 2023 Innovation Awards for Advancements in Health Technology

28.10.22PR NewswireAbbott's FreeStyle Libre® is Named Best Medical Technology in Last 50 Years by the Galien Foundation

27.10.22PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abbott Laboratories - ABT

19.10.22PR NewswireAbbott Reports Third-Quarter 2022 Results and Raises Full-Year EPS Guidance

19.10.22PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abbott Laboratories - ABT

12.10.22PR NewswireAbbott and The Home Edit Redesign the Medicine Cabinet to Help People Prepare for the Upcoming Virus Season

12.10.22PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Abbott Laboratories of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 31, 2022 - (NYSE: ABT)

08.10.22PR NewswireABBOTT LABORATORIES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Abbott Laboratories - ABT

06.10.22PR NewswireNew Study Published in The New England Journal of Medicine Demonstrates Abbott's FreeStyle Libre® 2 System Has Positive Impacts on Glucose Levels and Quality of Life

03.10.22PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abbott Laboratories - ABT

03.10.22PR NewswireCLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Abbott Investors of a Lead Plaintiff Deadline of October 31, 2022

29.09.22PR NewswireABT LAWSUIT ALERT: Levi & Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline

28.09.22PR NewswireAbbott Hosts Conference Call for Third-Quarter Earnings

17.09.22PR NewswireROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT

17.09.22PR NewswireLate-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technologies

16.09.22MyDividendsAbbott Laboratories kündigt 395. Quartalsdividende in Folge an

15.09.22PR NewswireAbbott Declares 395th Consecutive Quarterly Dividend

13.09.22PR NewswireABT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 31, 2022 in the Class Action Filed on Behalf of Abbott Laboratories Shareholders

12.09.22PR NewswireCLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Abbott Investors of a Lead Plaintiff Deadline of October 31, 2022

09.09.22PR NewswireHAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm's Attorneys, Infant Formula-Related Securities Fraud Class Action Filed

08.09.22PR NewswireThree-Year Data on World's Smallest Heart Device Show Benefits of Fixing Holes in Newborn Hearts Without Surgery

04.09.22PR NewswireROSEN, A LEADING LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT

02.09.22PR NewswireInvestor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Abbott Laboratories (ABT) Investors of Class Action and to Actively Participate

29.08.22PR NewswireNew Data Show Abbott's HeartMate 3™ Heart Pump Extends Life Beyond Five Years for Advanced Heart Failure Patients

23.08.22PR NewswireFDA Approves Abbott's New Spinal Cord Stimulation Device; Provides Tailored Relief to Multiple Pain Areas and Adds More Treatment Options for Evolving Pain Conditions

11.08.22PR NewswireNew Study Shows Abbott's Blood Test for Concussion Could Predict Outcomes from Brain Injury and Inform Treatment Interventions

04.08.22PR NewswireAbbott and WeightWatchers Partner to Support People Living with Diabetes in Attaining their Health Goals

26.07.22PR NewswireAbbott Introduces Canada's First Remote Neuromodulation Patient-Care Technology, NeuroSphere™ Virtual Clinic, to Treat People with Chronic Pain and Movement Disorders*

Abbott Laboratories News

Abbott Laboratories News: auf dieser Seite finden Sie alle Abbott Laboratories News und Nachrichten zur Abbott Laboratories Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Abbott Laboratories News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Abbott Laboratories News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.